Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV.
Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab.
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair.
Measurement and maintenance of reserve in multiple sclerosis.
Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.
Longitudinal extensive transverse myelitis with cervical epidural haematoma following dengue virus infection.
MicroRNA: Key regulators of oligodendrocyte development and pathobiology.
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Brain characterization using normalized quantitative magnetic resonance imaging.
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis.
Pharmacological treatment for memory disorder in multiple sclerosis.
Store-operated Calcium Entry into B Cells Regulates Autoimmune Inflammation.
S1P1 deletion in oligodendroglial lineage cells: Effect on differentiation and myelination.
Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation.
Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.
The impact of microglial activation on blood-brain barrier in brain diseases.
Application of metabolomics in autoimmune diseases: Insight into biomarkers and pathology.
Mutagenesis of the Aquaporin 4 Extracellular Domains Defines Restricted Binding Patterns of Pathogenic Neuromyelitis Optica IgG.
Chronic Inflammatory Pure Sensory Polyradiculoneuropathy: A Rare CIDP Variant With Unusual Electrophysiology.
Ultrasonography of MADSAM neuropathy: Focal nerve enlargements at sites of existing and resolved conduction blocks.
Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives.
Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice.
Pages
« first
‹ previous
…
697
698
699
700
701
702
703
704
705
…
next ›
last »